David Delucia
Chief Financial Officer · KYNTRA BIO, INC.
Individual
- 2025
- Sep 10, 2026
- 5
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Delucia files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Thane Wettig - $73K in KYNB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Delucia?
David Delucia is a corporate insider, tracked as Chief Financial Officer of KYNTRA BIO, INC. (KYNB). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Delucia submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
